论文部分内容阅读
目的：探讨脑出血再出血的发生率，型式及危险因素。方法：对１９８８年１月至１９９７年１２月在我院住院的７３４例再出血患者进行全面分析并与同期住院的无再发的脑出血患者进行比较。结果：１９８８年１月至１９９７年１２月在我院住院的７２４例脑出血患者，３４例再出血，再发率为４．７％，第１次出血到第２次出血时间最短４月，最长７２月，平均１８．１５±１４．２２月，第１次出血在基底区１８例，脑出血１６例，第１次出血在脑叶患者６２．５％有高血压，而第１次出血在基底节区患者１００％有高血压，脑出血再出血最常见再发型式为基底节→对侧基底节（１３例）和脑叶→对侧脑叶（１１例）。同时将脑出血再出血患者与同期住院的无再发的脑出血患者比较，发现脑叶出血以及不规则服用降血压药物为再出血的危险因素。结论：对高血压性脑出血患者提倡终生服用降压药物，对脑叶出血患者应常规脑血管造影或ＭＲＡ检查明确病因，尽早外科治疗，是防治再出血的关键。
Objective: To investigate the incidence, type and risk factors of cerebral hemorrhage and rebleeding. METHODS: A total of 734 patients with rebleeding hospitalized in our hospital from January 1988 to December 1997 were analyzed comprehensively and compared with those without recurrent cerebral hemorrhage hospitalized in the same period. Results: From January 1988 to December 1997 in our hospital 724 cases of cerebral hemorrhage patients, 34 cases of rebleeding, the recurrence rate was 4.7%, the first bleeding to the second bleeding time of the shortest in April, The longest 72 months, an average of 18.15 ± 14.22 months, the first bleeding in the basal area of 18 cases of cerebral hemorrhage in 16 cases, the first bleeding in 62.5% of patients with lobar hypertension, while the first Bleeding in patients with basal ganglia in 100% of patients with high blood pressure, cerebral hemorrhage rebleeding is the most common type of recurrence of the basal ganglia in the contralateral basal ganglia (13 cases) and the contralateral brain lobe (11 cases). At the same time, patients with hemorrhage and rebleeding were compared with those with recurrent and non-recurrent cerebral hemorrhage in the same period and found that lobar lobar hemorrhage and irregular taking antihypertensive drugs were risk factors for rebleeding. Conclusion: It is the key to prevention and cure of rebleeding that hypertensive intracerebral hemorrhage patients advocate taking antihypertensive drugs for life, and routine cerebrovascular angiography or MRA examination to clear the cause, as soon as possible surgical treatment.